{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-25-000064","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.122859+00:00","generated_at":"2026-05-22T04:37:54.620340+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evolent Health Q1 revenue down 24% to $483.6M; net loss widens to $72.3M","bullets":["Revenue $483.6M vs $639.7M YoY; net loss $72.3M vs $25.2M YoY.","Adjusted EBITDA $36.9M (7.6% margin) vs $54.1M (8.5% margin) YoY.","Five new revenue agreements added, including surgical management, oncology, and imaging expansions.","Performance Suite lives declined to 6,486 from 7,050 YoY; specialty technology lives rose to 77,079.","Company reiterates full-year 2025 revenue and Adjusted EBITDA outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-25-000064","json":"https://secwatch.observer/filing/0001628908-25-000064.json","markdown":"https://secwatch.observer/filing/0001628908-25-000064.md","text":"https://secwatch.observer/filing/0001628908-25-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/0001628908-25-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/evh-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:37:54.620340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}